National Academy of Medicine

It’s Time to Harmonize Clinical Trial Site Standards

Climbing costs and lengthy time frames of clinical trials are significant bottlenecks in medical product development. Despite the fact that scientifi
Read More

Real-World Evidence to Guide the Approval and Use of New Treatments

Research regarding new treatments (drugs, biological products, and high-risk devices) often begins with a broad assessment of disease
Read More

Disruptive Innovation and Transformation of the Drug Discovery and Development Enterprise

Declining or stagnant research and development (R&D) productivity has led many observers to argue that the
Read More

Daring to Change for Better Health, Partnerships, and Business

Now in its third year of data disclosure, the Physician Payments Sunshine Act has helped demystify financial connections between two critica
Read More